Skip to main content
. 2016 Jan 26;17(2):156. doi: 10.3390/ijms17020156

Table 1.

MicroRNA expressions of housekeeper candidates.

MicroRNA Mean Median SD CV (%) Rho BRCA * geNorm NormFinder **
CV (%) M All Prim Metas
hsa-miR-222-3p 26.97 26.77 2.13 7.88 0.86 21.6 1.14 0.95 0.63 1.29
hsa-miR-16-5p 25.70 24.84 2.78 10.80 0.83 9.3 1.26 1.28 1.42 0.61
hsa-miR-126-3p 25.17 24.70 2.08 8.26 0.80 9.6 1.03 0.62 0.50 0.86
hsa-miR-29a-3p 27.46 27.23 2.12 7.73 0.80 6.0 1.06 0.86 0.80 1.02
hsa-miR-146a-5p 27.82 27.54 2.00 7.18 0.76 20.3 1.03 0.75 0.67 0.93
hsa-miR-191-5p 25.21 24.68 2.42 9.60 0.71 10.8 1.21 0.98 1.06 0.74
U6snRNA 19.14 18.76 2.24 11.73 0.69 1.50 1.33 1.48 0.87
hsa-miR-199-3p 28.68 28.50 2.33 8.13 0.68 8.9 1.42 1.35 1.31 1.48
hsa-miR-628-5p 33.16 33.17 1.83 5.52 0.64 34.4 1.78 1.90 1.98 1.51
hsa-miR-145-5p 27.59 27.18 2.47 8.95 0.60 10.4 1.36 1.44 1.48 1.35
hsa-miR-150-5p 27.94 27.80 2.23 7.98 0.58 20.4 1.57 1.49 1.44 1.62
hsa-miR-196b-5p 31.63 31.62 2.03 6.43 0.50 20.4 1.68 1.85 1.49 1.84

SD: standard deviation; CV: coefficient of variation; rho: Spearman rank correlation, microRNAs with a rho ≥ 0.8 are greyed out; M: average expression stability value; PRIM: primary tumor; METAS: Metastasis; ALL: all 58 patients; * microRNAseq data of the The Cancer Genome Atlas (TCGA) breast adenocarcinoma (BRCA) analysis (including 755 patients); ** Stability values from NormFinder analysis are given based on the estimated intragroup variance for the given group.